Target intelligence / Profile preview

RNA, 7SL, cytoplasmic 420, pseudogene (RN7SL420P)

Target
RN7SL420P
Molecular classification
Other (pseudogene), Noncoding RNA pseudogene
01

Overview

RN7SL420P is a pseudogene derived from the 7SL RNA gene, which encodes the RNA scaffold of the signal recognition particle (SRP) complex involved in protein translocation in the endoplasmic reticulum[1][3][4]. 7SL RNA itself is a highly conserved structural RNA essential for SRP function[4]; however, RN7SL420P represents a non-functional, truncated, and genomically integrated copy that does not produce SRP RNA or participate in cellular protein translocation[5]. Pseudogenes such as RN7SL420P are generated by the reverse transcription of functional RNA back into DNA, resulting in sequences that are generally not expressed or biologically active in human cells[5]. RN7SL420P is not a protein-coding gene, not a receptor, and has no evidence of clinical, biomarker, or disease-related function.

Other names
RN7SL420P7SL pseudogene
02

Mechanism of action

None (no mechanism of action as a therapeutic target)

03

Biological functions

None (no known biological function; not expressed as functional RNA or protein)
04

Disease associations

None (no known role in disease; pseudogenes generally do not have direct functional or disease roles unless specifically documented, which is not the case for RN7SL420P)
05

Safety considerations

None (no safety concerns or therapeutic challenges, as it is not targeted)
06

Interacting drugs

None (no drugs interact with RN7SL420P or target it)
07

Biomarkers

None (RN7SL420P is not used as a biomarker)

Beyond the preview

Go deeper on RNA, 7SL, cytoplasmic 420, pseudogene (RN7SL420P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, 7SL, cytoplasmic 420, pseudogene (RN7SL420P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call